Immune Checkpoint Inhibitor Therapy in COPD-Concomitant Lung Cancer: A Review of Efficacy Outcomes and Mechanistic Insights.
The coexistence of chronic obstructive pulmonary disease (COPD) and lung cancer (LC) presents a complex clinical scenario with distinct pathological interactions. Beyond shared epidemiological and genetic risk factors, COPD reshapes the pulmonary immune microenvironment through reprogrammed immune-cell compartments, ab...